Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin–piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial

Hellen C. Barsosio(Liverpool School of Tropical Medicine), Feiko O. ter Kuile(Kenya Medical Research Institute), Miriam Taegtmeyer(University of Liverpool), Julie Gutman(Centers for Disease Control and Prevention), Victor Mwapasa(Kamuzu Central Hospital), James Dodd(North Bristol NHS Trust), Simon Kariuki(Kamuzu Central Hospital), Everlyne Delylah Ondieki(Kenya Medical Research Institute), Duolao Wang(Guangdong Medical College), Eric D Onyango(Kenya Medical Research Institute), Kamija S. Phiri(Liverpool School of Tropical Medicine), Christentze Schmiegelow(Copenhagen University Hospital), Mwayiwawo Madanitsa(Malawi University of Science and Technology), Kephas Otieno(Kenya Medical Research Institute), Kenneth Maleta(University of Malawi)
The Lancet
January 1, 2024
Cited by 21


Related Papers